Suraksha Diagnostic Quarterly Results
Suraksha Diagnostic quarterly results. In Sept 2025, Suraksha Diagnostic (SURAKSHA) reported revenue ₹80 Cr and net profit ₹9 Cr — revenue +17.6% YoY. Check SURAKSHA market capitalization to track the company's total market size over time.
SURAKSHA Quarterly Results — Revenue, Profit & EPS Highlights
Suraksha Diagnostic latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Review SURAKSHA PE ratio trends to evaluate earnings-based valuation against sector peers.
- Revenue of ₹80 Cr in Sept 2025 (+21.2% vs Mar 2025, +17.6% vs Sept 2024)
- Net Profit of ₹9 Cr in Sept 2025 (+28.6% vs Mar 2025, -10.0% vs Sept 2024)
- EBITDA of ₹25 Cr in Sept 2025 (+25.0% vs Mar 2025)
- Operating Margin of 31.0% in Sept 2025 (+2.0pp vs Mar 2025)
- Earnings Per Share of ₹1.73 in Sept 2025 (+21.8% vs Mar 2025)
Suraksha Diagnostic Quarterly Results — Revenue, EBITDA, Net Profit & EPS
SURAKSHA quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 80 | 66 | 74 | 78 | 68 | 21.2% | 17.6% |
| Net Profit (₹ Cr) | 9 | 7 | 9 | 7 | 10 | - | - |
| EBITDA (₹ Cr) | 25 | 20 | 25 | 24 | 25 | - | - |
| EPS (₹) | 1.73 | 1.42 | 1.80 | 1.44 | 1.94 | - | - |
| Operating Margin (%) | 31.0% | 29.0% | 33.0% | 30.0% | 35.0% | - | - |
SURAKSHA Share Price Trend — 1-Year Movement Across Quarterly Results
Suraksha Diagnostic 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit Suraksha Diagnostic share price chart.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
SURAKSHA vs Healthcare Services Peers — Quarterly Revenue, Profit & Market Cap
Suraksha Diagnostic latest quarter revenue and net profit vs Healthcare Services competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Apollo Hospitals
Mar 2026 |
₹116,947.25 Cr | 7985.0 | 6,660 | 551 | -6.3% | - | 8.3% | 216.9 |
|
Max Healthcare Inst…
Mar 2026 |
₹87,841.25 Cr | 917.0 | 2,191 | 342 | -9.0% | - | 15.6% | 260.5 |
|
Fortis Healthcare
Mar 2026 |
₹57,663.70 Cr | 763.8 | 2,375 | 271 | -7.7% | - | 11.4% | 217.0 |
|
Aster DM Healthcare
Mar 2026 |
₹42,146.56 Cr | 691.5 | 1,219 | 154 | -0.6% | +18.1% | 12.6% | 254.2 |
|
Global Health
Mar 2026 |
₹38,047.48 Cr | 1332.6 | 1,196 | 142 | -9.8% | - | 11.9% | 248.6 |
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores